Targeting Gallium to Cancer Cells through the Folate Receptor
The development of gallium(III) compounds as anti-cancer agents for both treatment and diagnosis is a rapidly developing field of research. Problems remain in exploring the full potential of gallium(III) as a safe and successful therapeutic agent or as an imaging agent. One of the major issues is th...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2008-01-01
|
Series: | Drug Target Insights |
Online Access: | https://doi.org/10.4137/DTI.S651 |